BMC Cancer

Table 2 Relationship between clinicopathological factors and metastasis in advanced gastric cancer

From: Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer

		lymph node metastasis			liver metastasis			peritoneal metastasis
variables	total	negative	positive	P value	negative	positive	P value	negative	positive	P value
age (years)
≤59	192	56	136		183	9		170	22
≥60	213	48	165	0.1394	194	19	0.1168	194	19	0.4142
gender
male	284	76	208		264	20		258	26
female	121	28	93	0.5345	113	8	>0.9999	106	15	0.3684
tumor location
upper	124	31	93		117	7		107	17
middle	152	40	112		143	9		134	18
lower	129	33	96	0.969	117	12	0.4303	123	6	0.0389
differentiation
differentiated	180	46	134		162	18		165	15
undifferentiated	225	58	167	>0.9999	215	10	0.0314	199	26	0.3225
lymphatic involvement
negative	125	68	57		119	6		119	6
positive	280	36	244	<0.0001	258	22	0.2974	245	35	0.0196
venous involvement
negative	195	60	135		190	5		180	15
positive	210	44	166	0.0303	187	23	0.0008	184	26	0.1386
serosal invasion
negative	240	91	149		226	14		235	5
positive	165	13	152	<0.0001	151	14	0.3236	129	36	<0.0001
tumor size (cm)
≤6	215	80	135		202	13		206	9
>6	190	24	166	<0.0001	175	15	0.5571	158	32	<0.0001
Plasma fibrinogen (mg/dl)
≤310	234	76	158		226	8		216	18
≥311	171	28	143	0.0002	151	20	0.0014	148	23	0.067

Back to article page

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com